Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 June 2020: Database Analysis

Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer

Hua Ge 1ABCDEF* , Yan Yan 2BCDE , Maozhao Yan 1CEF , Lingfei Guo 1EF , Kun Mao 1CF

DOI: 10.12659/MSM.923208

Med Sci Monit 2020; 26:e923208

Figure 3 Kaplan-Meier survival curves comparing the increased and decreased expression of SATB1 in different types of cancer in PrognoScan. (A–E) Survival curves of DSS, OS, RFS, DFS, and DMFS in breast cancer cohorts [GSE3494-GPL96 (n=236), GSE9893 (n=155), GSE2990 (n=125), and GSE4922 (n=249)]. (F–I) Survival curves of RFS, OS, and DSS in lung cancer cohorts [GSE31210 (n=204), Jacob-00182-MSK (n=104), GSE13213 (n=117), and GSE14814 (n=90)]. (J, K) Survival curves of OS in brain cancer cohorts [GSE4271-GPL96 (n=77), MGH-glioma (n=50)]. (L) Survival curves of OS in prostate cancer cohorts [GSE16560 (n=281)]. (M) Survival curves of OS in skin cancer cohorts [GSE19234 (n=38)]. (N) Survival curves of DSS in bladder cancer cohorts [GSE13507 (n=165)]. (O) Survival curves of DSS in eye cancer cohorts [GSE22138 (n=63)]. DSS – disease-specific survival; OS – overall survival; RFS – relapse-free survival; DFS – disease-free survival; DMFS – distant metastasis free survival.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750